<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04730011</url>
  </required_header>
  <id_info>
    <org_study_id>KJPP 2020-02053</org_study_id>
    <nct_id>NCT04730011</nct_id>
  </id_info>
  <brief_title>Short and Intensive Treatment of Children and Adolescents With Obsessive-Compulsive Disorder</brief_title>
  <official_title>Short and Intensive Treatment of Children and Adolescents With Obsessive-Compulsive Disorder - A Study to Evaluate the Effectiveness of an Intensive Treatment Week: &quot;A Future Without Constraint&quot;</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Susanne Walitza</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Psychiatric University Hospital, Zurich</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Obsessive-compulsive disorders are very damaging illnesses; they can already appear in&#xD;
      childhood and adolescence and become extremely chronic. With an average prevalence from 1-3%,&#xD;
      they are among the most common psychiatric disorders in children and adolescents. 40% of&#xD;
      diagnosed children and young adults display persistent and increasingly chronic symptoms and&#xD;
      O-C disorders are highly complex syndromes with broadly varying manifestations. They arise&#xD;
      from obsessive thoughts (ideas/thoughts or impulses, often senseless or tortured, that impose&#xD;
      themselves or intrude) and obsessive behavior (ritualized patterns that must be frequently&#xD;
      repeated).&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 1, 2021</start_date>
  <completion_date type="Anticipated">December 31, 2028</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2028</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Symptoms severity of obsessive and compulsive symptoms in children and adolescents</measure>
    <time_frame>12 months</time_frame>
    <description>The clinician-report questionnaire (BY-BOCS) contains 19 items designed to assess severity of obsessive and compulsive symptoms in children and adolescents.The test uses a 4-point scale to rate the severity of their obsessive compulsive behaviors. Higher score means a worse outcome.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Obsessive-Compulsive Disorder</condition>
  <arm_group>
    <arm_group_label>Treatment Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients are treated based on the Cognitive Behavioral Psychotherapy. This includes individual and group sessions over one week.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Short and Intensive Treatment</intervention_name>
    <description>Intensive Treatment Week with behavioural psychotherapy</description>
    <arm_group_label>Treatment Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Obsessive-Compulsive Disorder diagnosis&#xD;
&#xD;
          -  Male and female patients from 8-18 years&#xD;
&#xD;
          -  Good German language speaking skills&#xD;
&#xD;
          -  IQ of at least 75&#xD;
&#xD;
          -  At least four days' participation in the treatment/therapy week&#xD;
&#xD;
          -  Written agreement after clear explanation&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        - No complete participation in the intensive week treatment/therapy&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>8 Years</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Susanne Walitza, Prof. Dr. med. Dipl.-Psych.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Sponsor GmbH</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Susanne Walitza, Prof. Dr. med. Dipl.-Psych.</last_name>
    <phone>+41 (0)43 499 26 26</phone>
    <email>susanne.walitza@puk.zh.ch</email>
  </overall_contact>
  <location>
    <facility>
      <name>Psychiatric University Clinics, Department of Child and Adolescent Psychiatry</name>
      <address>
        <city>Zurich</city>
        <state>ZH</state>
        <zip>8032</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Susanne Walitza, Prof. Dr. med. Dipl.-Psych.</last_name>
      <phone>+41 43 499 26 26</phone>
      <email>susanne.walitza@puk.zh.ch</email>
    </contact>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>January 25, 2021</study_first_submitted>
  <study_first_submitted_qc>January 25, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">January 29, 2021</study_first_posted>
  <last_update_submitted>January 25, 2021</last_update_submitted>
  <last_update_submitted_qc>January 25, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">January 29, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Psychiatric University Hospital, Zurich</investigator_affiliation>
    <investigator_full_name>Susanne Walitza</investigator_full_name>
    <investigator_title>Head of the Department of Child and Adolescent Psychiatry</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Compulsive Personality Disorder</mesh_term>
    <mesh_term>Obsessive-Compulsive Disorder</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

